Chief Architect — Innovative Medicine
The Chief Architect, Innovative Medicine Sector is the senior architecture leader responsible for defining and governing the technology architecture strategy across the Innovative Medicine sector, including R&D, Supply Chain, Commercial, Data, AI, Cloud, Integration, Security, and Enterprise platforms.
This role establishes the sector-wide architectural vision, principles, reference designs, standards, and governance model that guide technology investments and ensure alignment with business strategy, digital transformation priorities, and enterprise technology direction.
The Chief Architect partners closely with sector business leaders, product and platform teams, Technology Services, Information Security & Risk Management, Enterprise Architecture, and architects across other J&J sectors to promote common enterprise architecture principles, reusable platforms, and consistent technology decision-making.
The role serves as the architecture steward for Innovative Medicine, ensuring solutions are scalable, secure, interoperable, compliant, resilient, AI-ready, and aligned to both sector-specific needs and broader enterprise technology standards.
The role will lead a distributed team of 20+ architects and is accountable for advancing modern architecture ways of working, including the adoption of GenAI to accelerate blueprint creation, architectural analysis, pattern discovery, design documentation, standards compliance, and architecture decision support.
Innovative Medicine sector: R&D, Supply Chain, and Commercial
Titusville, NJ • Raritan, NJ • Spring House, PA • Beerse, Belgium
Johnson and Johnson Innovative Medicine
15–25% domestic and international